WENA Anew Medical Inc.: Bozor qiymatining balans qiymatiga nisbati

Anew Medical, Inc. (WENA) kompaniyasining neyrodegeneratsiyaga qarshi ishlanmalari makroiqtisodiy sikllar va mavsumiylikdan butunlay mustaqildir. P/BV koeffitsiyenti tarixi ushbu barqarorlikni vizuallashtiradi, bunda -7.32 ushbu metrikaning joriy darajasini ko'rsatadi. Anew Medical, Inc. (WENA) Altsgeymer va Parkinson kasalliklari uchun gen terapiyasi orqali risklarni minimallashtirib, o'zining R&D laboratoriyalari va hamkor ishlab chiqarish liniyalarida yuqori operatsion tayyorgarlikni saqlab qolmoqda.

anewmeds.com (WENA) - Bozor qiymatining balans qiymatiga koeffitsiyenti 25.06.2024dan 17.09.2024gacha

Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlari qiymati bilan solishtirib, kapitalning moddiy aktivlarga nisbatan qanchalik hadda ortiq baholangani yoki past baholanganini ko'rsatadi. Bozor qiymatining buxgalteriya qiymatiga nisbati koeffitsientining joriy tendentsiyasini tahlil qilish orqali investor bozor premiumining asoslanganligini baholaydi. Anew Medical, Inc. (WENA) uchun qarzlarning yo'qligi moliyaviy xatarlarni minimallashtiradi, biotexnologik ishlanmalardan iborat patent portfeli esa aktivlar qiymatini saqlab qolish uchun fundamental bazani yaratadi.

Raqobatchilar tahlili

BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|neurocrine.com (NBIX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati trevitherapeutics.com|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. (PRAX)|Anavex - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CBLL (CeriBell Corp)|Prothena (PRTA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ALEC: Kapitallashuvning sof aktivlarga nisbati|annexonbio.com (ANNX) - Kapitallashuvning sof aktivlarga nisbati|OMER (omeros.com) - Kapitallashuvning sof aktivlarga nisbati|Neurogene Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati AC Immune Corp|Kapitallashuvning sof aktivlarga nisbati Voyager Corp (VYGR)|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|SCLX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati TVGN (Tevogen Bio)|ACOG: Kapitallashuvning balans qiymatiga nisbati|Cognition Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Inhibikase Pharma IKT|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Assertio|COYA (Coya Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VistaGen Therapeutics Inc|Bozor qiymatining balans qiymatiga nisbati Ovid Therapeutics Inc. (OVID)|Bozor qiymatining balans qiymatiga nisbati ABOS (Acumen Pharmaceuticals, Inc)|CervoMed Inc. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ATHE|Clene Nanomedicine - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PepGen Inc. PEPG|Jupiter Neurosciences (JUNS) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RLMD|ANVS (Annovis Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Grace Tx (GRCE)|Kapitallashuvning sof aktivlarga nisbati AIFF (Firefly Neuroscience)|Balans qiymatiga nisbatan bozor kapitallashuvi anewmeds.com|NeuroSense Therapeutics Ltd. - Kapitallashuvning sof aktivlarga nisbati|RVPH - Kapitallashuvning sof aktivlarga nisbati|MetaVia, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neuraxis.com|heliusmedical.com (HSDT) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PASG|NEUP (Neuphoria Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Minerva|Bozor qiymatining balans qiymatiga nisbati Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|PTIX: Kapitallashuvning sof aktivlarga nisbati|KTTA - Bozor kapitallashuvining balans qiymatiga nisbati|cortigent.com (CRGT) - Bozor qiymatining balans qiymatiga nisbati|avenuetx.com - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati BrainStorm Cell Therapeutics|Bozor qiymatining balans qiymatiga koeffitsiyenti Cara Therapeutics Inc. CARA|Bozor kapitallashuvining balans qiymatiga nisbati CHRO|Bozor kapitallashuvining balans qiymatiga nisbati eliemtx.com (ELYM)|Bozor qiymatining balans qiymatiga nisbati Intra-Cellular Therapies, Inc. ITCI|LBPH: Kapitallashuvning balans qiymatiga nisbati|Marinus Pharmaceuticals, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti NKGen Biotech Inc|NRBO (NeuroBo) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati Sage Therapeutics Inc|Kapitallashuvning sof aktivlarga nisbati SNPX|TRVN: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Vigil Neuroscience (VIGL)|Kapitallashuvning sof aktivlarga nisbati Cerevel Therapeutics Inc CERE